Angelo Lombardo

Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis.

Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing.

IL-10-Engineered Human CD4 Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.

Genome editing for scalable production of alloantigen-free lentiviral vectors for gene therapy.

Therapeutic gene editing in CD34 hematopoietic progenitors from Fanconi anemia patients.

T-cell defects in patients with germline mutations account for combined immunodeficiency.

Gene Modification and Three-Dimensional Scaffolds as Novel Tools to Allow the Use of Postnatal Thymic Epithelial Cells for Thymus Regeneration Approaches.

Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.

Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced and Genetic Engineering.

Altered Cl homeostasis hinders forebrain GABAergic interneuron migration in a mouse model of intellectual disability.

Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene.

Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency.

Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I iPSCs for β cell replacement.